PIEZO2 — Piezo Type Mechanosensitive Ion Channel Component 2
Overview
PIEZO2 encodes the principal mechanosensitive ion channel responsible for light touch sensation and proprioception in the mammalian nervous system. PIEZO2 is a remarkably large trimeric transmembrane protein that directly converts mechanical force into electrical signals, functioning as the molecular basis of gentle touch, vibration detection, and body position sense. The discovery of PIEZO channels by Ardem Bhattacharyya (Patapoutian) and colleagues earned the 2021 Nobel Prize in Physiology or Medicine[@coste2010].
PIEZO2 is relevant to neurodegeneration because its dysfunction causes inherited sensory and motor neuropathies, and because mechanosensitive signaling pathways influence neuroinflammation, neuronal survival, and glial activation. Gain-of-function mutations cause distal arthrogryposis syndromes, while loss-of-function mutations cause a distinctive syndrome of absent proprioception and touch insensitivity. PIEZO2's expression in [dorsal root ganglia](/brain-regions/dorsal-root-ganglia) sensory neurons, [Merkel cells](/cell-types/merkel-cells), and proprioceptors positions it at the interface between sensory processing and neurodegeneration[@ranade2014].
Gene Structure and Expression
PIEZO2 is located on chromosome 18p11.22 and spans approximately 430 kb, one of the largest genes in the genome. It encodes a 2822-amino acid protein that forms functional homotrimeric channels. Each subunit contains:
Extracellular blade domains (N-terminal region): 38 transmembrane helices arranged as peripheral "propeller blades" that sense membrane tension and curvature
Anchor domain: Links the mechanosensing blades to the pore module
Central pore module: Three inner helices from each subunit form a cation-selective ion channel pore
C-terminal extracellular domain (CED): Contains the selectivity filter and is accessible for pharmacological modulation
Beam and latch: Intracellular lever-like structures that transmit force from the blades to the pore gate
PIEZO2 is expressed in a highly cell-type-specific pattern in the nervous system:
Dorsal root ganglion (DRG) neurons: Large-diameter Aβ mechanoreceptors for light touch and proprioception
Trigeminal ganglion neurons: Facial and oral mechanoreception
Proprioception: In muscle spindle afferents, PIEZO2 senses muscle stretch, providing the brain with continuous information about limb position and movement
Airway stretch sensing: PIEZO2 in pulmonary sensory neurons mediates the Hering-Breuer inflation reflex
Channel Biophysics
PIEZO2 has distinctive biophysical properties:
Rapid inactivation: Mechanically activated currents inactivate within milliseconds, enabling detection of dynamic stimuli
Cation selectivity: Permeant to Na+, K+, and Ca2+ with moderate calcium permeability (PCa/PNa ~4.5)
Force sensitivity: Activated by membrane tension, osmotic swelling, and direct pipette poking
Modulation: Channel kinetics are modulated by STOML3 (stomatin-like protein 3), which enhances mechanosensitivity
Neurodevelopmental Functions
PIEZO2 plays essential roles in nervous system development:
Axon guidance: Mechanosensitive signaling through PIEZO2 influences growth cone navigation
Neuronal migration: PIEZO2-mediated calcium transients guide neuronal positioning during cortical development
Circuit refinement: Activity-dependent PIEZO2 signaling contributes to somatosensory circuit maturation[@koser2016]
Disease Associations
Distal Arthrogryposis Type 5 (DA5)
Gain-of-function PIEZO2 mutations cause distal arthrogryposis type 5:
Joint contractures: Fixed flexion deformities of distal joints (fingers, toes)
Limited eye movement: Restrictive ophthalmoplegia
Mechanism: Gain-of-function mutations slow channel inactivation, leading to excessive mechanotransduction and sustained muscle contraction during development
Distal arthrogryposis: Similar to DA5 with joint contractures
Cleft palate: Orofacial involvement
Short stature: Growth restriction
Ptosis: Eyelid drooping
PIEZO2 Deficiency Syndrome (Loss-of-Function)
Biallelic loss-of-function PIEZO2 mutations cause a distinctive neurological syndrome:
Absent proprioception: Complete loss of body position sense, leading to sensory ataxia — patients cannot stand with eyes closed (positive Romberg sign) and have severely impaired joint position sense
Loss of light touch: Inability to detect gentle skin contact, with preserved pain and temperature sensation
Absent vibration sense: Complete loss of vibratory perception
Normal pain: Nociceptive pathways (mediated by [TRPV1](/genes/trpv1) and other channels) remain intact
Hip dysplasia: Developmental skeletal abnormalities
Progressive scoliosis: Spinal deformity from proprioceptive denervation
Motor coordination: Remarkably, patients develop compensatory strategies using vision and vestibular input[@chesler2016]
Relevance to Neurodegeneration
PIEZO2 intersects with neurodegeneration through several mechanisms:
Sensory neuronopathy: PIEZO2-expressing large-diameter DRG neurons are preferentially lost in certain sensory neurodegenerative conditions, and PIEZO2 dysfunction may contribute to proprioceptive decline in aging
Microglial mechanosensing: [Microglia](/cell-types/microglia-neuroinflammation) express mechanosensitive channels and respond to tissue stiffness changes. While [PIEZO1](/genes/piezo1) is the dominant microglial mechanosensor, PIEZO2 may contribute to mechanosensitive inflammatory signaling in the brain
[Amyloid-beta](/proteins/amyloid-beta) and tissue stiffness: Amyloid plaque deposition alters brain tissue mechanics. Mechanosensitive signaling through Piezo channels may transduce these mechanical changes into cellular responses
Peripheral neuropathy in AD/PD: Proprioceptive deficits and gait instability in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) may partly reflect PIEZO2-expressing neuron dysfunction in DRG[@nonomura2017]
Age-dependent decline: Touch sensitivity and proprioception decline with aging, potentially reflecting age-related changes in PIEZO2 expression or function
Therapeutic Implications
Pharmacological Modulation
Yoda1: Selective [PIEZO1](/genes/piezo1) agonist (does not activate PIEZO2), used as research tool
[Coste B et al, Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels (2010)](https://pubmed.ncbi.nlm.nih.gov/20813920/)
[Ranade SS et al, Piezo2 is the major transducer of mechanical forces for touch sensation in mice (2014)](https://pubmed.ncbi.nlm.nih.gov/25480887/)
[Wu J et al, Inactivation of mechanically activated Piezo1 ion channels is determined by the C-terminal extracellular domain and the inner pore helix (2017)](https://pubmed.ncbi.nlm.nih.gov/28119082/)
[Koser DE et al, Mechanosensing is critical for axon growth in the developing brain (2016)](https://pubmed.ncbi.nlm.nih.gov/27545714/)
[Coste B et al, Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of distal arthrogryposis (2013)](https://pubmed.ncbi.nlm.nih.gov/23542699/)
[Chesler AT et al, The role of PIEZO2 in human mechanosensation (2016)](https://pubmed.ncbi.nlm.nih.gov/27383785/)
[Nonomura K et al, Piezo2 senses airway stretch and mediates lung inflation-induced apnoea (2017)](https://pubmed.ncbi.nlm.nih.gov/28002412/)
[Szczot M et al, PIEZO2 mediates injury-induced tactile pain (2018)](https://pubmed.ncbi.nlm.nih.gov/29370074/)
[Woo SH et al, Piezo2 is required for Merkel-cell mechanotransduction (2014)](https://pubmed.ncbi.nlm.nih.gov/25480889/)
[Wang L et al, Structure and mechanogating of the mammalian tactile channel PIEZO2 (2019)](https://pubmed.ncbi.nlm.nih.gov/31597131/)
Pathway Diagram
The following diagram shows the key molecular relationships involving PIEZO2 — Piezo Type Mechanosensitive Ion Channel Component 2 discovered through SciDEX knowledge graph analysis: